Oncogene Science, Inc., 106 Charles Lindbergh Blvd., Uniondale, NY 11553

Received 6/2/97; Accepted 6/4/97

6. ACKNOWLEDGMENTS

The author’s drug discovery research is partly supported by an Small Business Innovative Research (SBIR) grant from NIAID, "Inhibition of the HIV-1 Rev transactivator", grant number 5 R44 AI34685-03